RVMD
$39.47
Revenue | $0Mn |
Net Profits | $-213.42Mn |
Net Profit Margins | -Inf% |
Revolution Medicines Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2025. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its revenue since last 3-months.
Revolution Medicines Inc’s net profit fell -83.97% since last year same period to $-213.42Mn in the Q1 2025. On a quarterly growth basis, Revolution Medicines Inc has generated -9.69% fall in its net profits since last 3-months.
Revolution Medicines Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2025. On a quarterly growth basis, Revolution Medicines Inc has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.75 |
EPS Estimate Current Year | -0.75 |
Revolution Medicines Inc’s earning per share (EPS) estimates for the current quarter stand at -0.75 - a 22.24% jump from last quarter’s estimates.
Revolution Medicines Inc’s earning per share (EPS) estimates for the current year stand at -0.75.
Earning Per Share (EPS) | -1.13 |
Revolution Medicines Inc’s earning per share (EPS) fell -61.43% since last year same period to -1.13 in the Q1 2025. This indicates that the Revolution Medicines Inc has generated -61.43% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-07 | -0.75 | -1.13 | -50.67% |